Company Overview - Dazhenglin Pharmaceutical Group Co., Ltd. (大参林) was established in February 1999 and has a registered capital of approximately 1.14 billion RMB [1] - The company is involved in the wholesale and retail of pharmaceuticals, as well as the import and export of drugs [1] - The legal representative is Ke Guoqiang, and the company is co-owned by Ke Yunfeng, Ke Jinlong, and Ke Kangbao [1] Incident Summary - A customer, Ms. Zhang, reported sudden hearing loss after using ear drops recommended by a Dazhenglin pharmacy employee, who diagnosed her with otitis media without proper examination [1] - The pharmacy staff claimed to have a licensed pharmacist certificate but lacked medical qualifications, and the diagnosis was made via an online platform [1] - The pharmacy's response to Ms. Zhang's complaint indicated that compensation would only be provided if a hospital could prove the medication caused her hearing loss, with a maximum compensation of 200 RMB offered [1] Legal and Financial Implications - Dazhenglin has faced multiple lawsuits related to product liability and contract disputes in the past, indicating a history of legal challenges [1] - The incident raises concerns about the company's customer service and the potential financial impact from legal claims and reputational damage [1]
女子称用药后耳聋药店不管治疗费 大参林称需医院证明